ISLB 2024

A meeting endorsed by the ISLB is an event where the overall educational program has been reviewed by the ISLB and the meeting represents a multidisciplinary educational approach which meets minimum applicable criteria set by our society. However, the ISLB is not a planner and does not control the content, logistics, or any financial aspects related to endorsed meetings.

Events name: 20th Anniversary Circulating Tumor Cells
Date: 05/24/2024 – 05/25/2024

Unveiling the impact of circulating tomor cells: Two decades of discovery and clinical advancements in solid tumors.

Events name: FOCUS on TOP
Date: 18 March 2024

The “Focus on TOP” symposium aims to introduce an innovative format in tune with this new context. The event will feature presentations from opinion leaders coming from both the clinical and preclinical settings, as well as a critical analysis of the state of the art in research and development.

Events name: IASLC GLOBAL SURVEY ON BIOMARKER TESTING IN LUNG CANCER
Date: 23 March 2024

Biomarker testing is essential in lung cancer care, allowing for personalized diagnosis and treatment. Survey closes March 23, 2024.

Events name: BIOMARKERS SUMMIT IN BREAST CANCER: ESCALATING AND DE-ESCALATING STRATEGIES , 4/04/2024 | FAD sincrona webinar
Date: 4 April 2024

The meeting has the dual purpose of considering the state of the art related to the changing scenario of therapeutic indications in advanced breast cancer, and, in particular, considering the positioning of new therapies, and how these may impact recent research. The meeting aims also to evaluate upcoming development strategies to better integrate the laboratory and clinic in the setting of these cancers.
As such, the meeting is aimed primarily for physicians and other professionals with an interest in biomarkers in breast cancers.

Events name: Tecan Annual Cancer Symposium
Date: 7 May 2024

Events name: 20th Anniversary of Circulating Tumor Cells Organized by ISLB
Date: 24 May 2024 – 25 May 2024

Unveiling the Impact of Circulating Tumor Cells: Two Decades of Discovery and Clinical Advancements in Solid Tumors.

Chairs:
Dr Massimo Cristofanilli
Dr Maria José Serrano

Centro Pfizer- University of Granada- Junta De Andalucia De Genomica E Investigación Oncologica
Granada, Spain

Events name: EACR 2024 Congress
Date: 10 – 13 June 2024

We’re inviting the cancer research community to join us in Rotterdam, Netherlands on 10 – 13 June 2024 for an inspiring interactive meeting covering the latest breakthroughs in cancer research.